M&A Science

Buying Public Companies

07.26.2022 - By Kison PatelPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Pranjal Gambhir, and Doretta Mistras, Managing Director - Global Investment Banking, Healthcare at Citi The M&A; process varies when dealing with a public vs private company. To many, acquiring a public company is more ideal. First-time acquirers need to be aware of the differences between acquiring a public company and acquiring a private company. In this episode of the M&A; Science Podcast, Pranjal Gambhir and Doretta Mistras, both Managing Directors, Global Investment Banking, Healthcare at Citi, talk about how to buy public companies.  To check out Affinity’s 2022 M&A; Benchmark Report, download it for free at http://affinity.co/kison Liked today's episode? Unlock over 50 courses taught by top-tier M&A; practitioners by joining the M&A; Science Academy. Use code “podcast” on the sign-up page for a 20% discount, available on either monthly or annual plans. https://www.mascience.com/academy Want to learn about upcoming interviews, events, and industry trends? Sign up for our weekly newsletter. https://www.mascience.com/newsletter-signup If you’re a head of corporate development and looking to build up a world-class M&A; team, reach out to me at [email protected]. This episode is sponsored by FirmRoom, the fastest virtual data room used to get deals done. Leave the pay-per-page world behind by going to https://firmroom.com/

More episodes from M&A Science